The result showed that a small group of DLBCL (10.5%, 8/76) was clustered together with PMBCL as Cluster_2, with amplification of JAK2 (100%,8/8) and PD-L2 (75.0%%,6/8)(Fig. 1a). The gene discussed is JAK2; the disease is diffuse large B-cell lymphoma.